60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
- In health
- Mar 11, 2026, 11:24 AM
- By Sixty Degrees Pharmaceuticals
- 0 Views

All three patients in 60 Degrees Pharma’s expanded access study were cured of relapsing babesiosis after tafenoquine treatment, supporting guideline review
- All three patients enrolled in study have been cured, confirming high cure rate of tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publication
- Company calls fo… [+12718 chars]
- health
- Mar 30, 2026, 03:28 AM
- health
- Mar 30, 2026, 03:21 AM
- health
- Mar 29, 2026, 10:34 PM
- health
- Mar 29, 2026, 05:34 PM
- health
- Mar 29, 2026, 12:30 PM
- health
- Mar 29, 2026, 12:22 PM
- health
- Mar 29, 2026, 12:20 PM
- health
- Mar 29, 2026, 12:18 PM
- health
- Mar 29, 2026, 12:16 PM
- health
- Mar 29, 2026, 12:16 PM